The Director of Strategic Alliances & External Engagement is a senior leader within Medical Affairs responsible for developing and executing a cross-functional coordinated engagement strategy that strengthens Mineralys’ scientific leadership in cardio-renal-metabolic disorders. This role drives collaboration across academic institutions, professional societies, patient advocacy organizations, and other key external stakeholders to support the full product lifecycle of lorundrostat, Mineralys’ first-in-class aldosterone synthase inhibitor. By aligning external partnerships with the company’s medical and corporate objectives, this leader ensures that actionable insights, scientific data, and real-world evidence shape how Mineralys advances its mission to improve outcomes for patients with uncontrolled and resistant hypertension.